GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biolife Sciences Inc (OTCPK:BLFE) » Definitions » Effective Interest Rate on Debt %

Biolife Sciences (Biolife Sciences) Effective Interest Rate on Debt % : 0.00% (As of May. 2008)


View and export this data going back to 2005. Start your Free Trial

What is Biolife Sciences Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Biolife Sciences's annualized positive value of Interest Expense for the quarter that ended in May. 2008 was $0.00 Mil. Biolife Sciences's average total debt for the quarter that ended in May. 2008 was $2.68 Mil. Therefore, Biolife Sciences's annualized Effective Interest Rate on Debt % for the quarter that ended in May. 2008 was 0.00%.


Biolife Sciences Effective Interest Rate on Debt % Historical Data

The historical data trend for Biolife Sciences's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biolife Sciences Effective Interest Rate on Debt % Chart

Biolife Sciences Annual Data
Trend Nov04 Nov05 Nov06 Nov07
Effective Interest Rate on Debt %
- - - -

Biolife Sciences Quarterly Data
Nov04 Feb05 May05 Aug05 Nov05 Feb06 May06 Aug06 Nov06 Feb07 May07 Aug07 Nov07 Feb08 May08
Effective Interest Rate on Debt % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Biolife Sciences's Effective Interest Rate on Debt %

For the Medical Instruments & Supplies subindustry, Biolife Sciences's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biolife Sciences's Effective Interest Rate on Debt % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biolife Sciences's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Biolife Sciences's Effective Interest Rate on Debt % falls into.



Biolife Sciences Effective Interest Rate on Debt % Calculation

Biolife Sciences's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Nov. 2007 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Nov. 2006 )+Total Debt  (A: Nov. 2007 ))/ count )
=-1  *  0/( (2.633+2.66)/ 2 )
=-1  *  0/2.6465
=0.00 %

where

Total Debt  (A: Nov. 2006 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0.297 + 2.336
=2.633

Total Debt  (A: Nov. 2007 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0.206 + 2.454
=2.66

Biolife Sciences's annualized Effective Interest Rate on Debt % for the quarter that ended in May. 2008 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Feb. 2008 )+Total Debt  (Q: May. 2008 ))/ count )
=-1  *  0/( (2.504+2.858)/ 2 )
=-1  *  0/2.681
=0.00 %

where

Total Debt  (Q: Feb. 2008 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0.171 + 2.333
=2.504

Total Debt  (Q: May. 2008 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0.421 + 2.437
=2.858

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (May. 2008) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.


Biolife Sciences  (OTCPK:BLFE) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.


Biolife Sciences Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Biolife Sciences's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.


Biolife Sciences (Biolife Sciences) Business Description

Traded in Other Exchanges
N/A
Address
2831 Street Rose Parkway, No. 200, Henderson, NV, USA, 89052
Biolife Sciences Inc is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. The company's technologies include antimicrobial copper air filters and copper-infused textiles. Its revenues are primarily generated from the sale of sanitation products.
Executives
Arthur Viola director, 10 percent owner, officer: CEO

Biolife Sciences (Biolife Sciences) Headlines

From GuruFocus

Rhino Novi Announces Name Change and New CEO

By Marketwired Marketwired 09-15-2020